Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Prodrugs of PKC modulators show enhanced HIV latency reversal and an expanded therapeutic window
Jack L. Sloane, Nancy L. Benner, Katherine E. Near, et al.
Proceedings of the National Academy of Sciences (2020) Vol. 117, Iss. 20, pp. 10688-10698
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

The landscape of small-molecule prodrugs
Zachary Fralish, Ashley Chen, Shaharyar M. Khan, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 5, pp. 365-380
Closed Access | Times Cited: 31
The Current Status of Latency Reversing Agents for HIV-1 Remission
Anthony Rodari, Gilles Darcis, Carine Van Lint
Annual Review of Virology (2021) Vol. 8, Iss. 1, pp. 491-514
Open Access | Times Cited: 100
Activators and Inhibitors of Protein Kinase C (PKC): Their Applications in Clinical Trials
Takahito Kawano, Junichi Inokuchi, Masatoshi Eto, et al.
Pharmaceutics (2021) Vol. 13, Iss. 11, pp. 1748-1748
Open Access | Times Cited: 75
Euphorbiaditerpenoids: isolation, structure, bioactivity, biosynthesis, and synthesis (2013–2021)
Zha‐Jun Zhan, Shen Li, W. L. Alexis Chu, et al.
Natural Product Reports (2022) Vol. 39, Iss. 11, pp. 2132-2174
Closed Access | Times Cited: 62
HIV Persistence, Latency, and Cure Approaches: Where Are We Now?
T Chou, Nishad S. Maggirwar, Matthew D. Marsden
Viruses (2024) Vol. 16, Iss. 7, pp. 1163-1163
Open Access | Times Cited: 10
Plant Metabolic Gene Clusters: Evolution, Organization, and Their Applications in Synthetic Biology
Revuru Bharadwaj, Sarma Rajeev Kumar, Ashutosh Sharma, et al.
Frontiers in Plant Science (2021) Vol. 12
Open Access | Times Cited: 50
Structural anatomy of Protein Kinase C C1 domain interactions with diacylglycerol and other agonists
Sachin Katti, Inna V. Krieger, Jihyae Ann, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 30
Tigliane and daphnane diterpenoids from Thymelaeaceae family: chemistry, biological activity, and potential in drug discovery
Kouharu Otsuki, Wei Li
Journal of Natural Medicines (2023) Vol. 77, Iss. 4, pp. 625-643
Open Access | Times Cited: 21
Highly anticipated natural diterpenoids as an important source of new drugs in 2013–2023
Yingjie Wang, Peng Tang, Wen‐Chao Tu, et al.
Chinese Chemical Letters (2024) Vol. 36, Iss. 1, pp. 109955-109955
Closed Access | Times Cited: 6
Enhancing HIV-1 latency reversal through regulating the elongating RNA Pol II pause-release by a small-molecule disruptor of PAF1C
Shimaa Soliman, William J. Cisneros, Marta Iwanaszko, et al.
Science Advances (2023) Vol. 9, Iss. 10
Open Access | Times Cited: 15
Balancing skeleton and functional groups in total syntheses of complex natural products: a case study of tigliane, daphnane and ingenane diterpenoids
Zhi Liu, Zhengwei Ding, Kai Chen, et al.
Natural Product Reports (2021) Vol. 38, Iss. 9, pp. 1589-1617
Closed Access | Times Cited: 30
A green and simple method for enrichment of major diterpenoids from the buds of Wikstroemia chamaedaphne with macroporous resins and their activation of latent human immunodeficiency virus activity
Shi-Fei Li, Gong-Lu Li, D Chen, et al.
International Journal of Biological Macromolecules (2024) Vol. 272, pp. 132932-132932
Open Access | Times Cited: 4
Wikstrol B reactivates latent human immunodeficiency virus (HIV-1) via the nuclear factor-κB (NF-κB) pathway
Ziyao Wu, Kang Ding, Wenli Liu, et al.
Phytomedicine (2025) Vol. 141, pp. 156667-156667
Closed Access
Isolation, Synthesis, and Structure–Activity Relationship Study on Daphnane and Tigliane Diterpenes as HIV Latency-Reversing Agents
Ahmed H. El‐Desoky, Keisuke Eguchi, Naoki Kishimoto, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 4, pp. 3460-3472
Open Access | Times Cited: 18
Synthesis and preclinical evaluation of tigilanol tiglate analogs as latency-reversing agents for the eradication of HIV
Zachary O. Gentry, Owen D. McAteer, Jennifer L. Hamad, et al.
Science Advances (2025) Vol. 11, Iss. 4
Open Access
Activating PKC-ε induces HIV expression with improved tolerability
Alivelu Irrinki, Jasmine Kaur, Baljit Randhawa, et al.
PLoS Pathogens (2025) Vol. 21, Iss. 2, pp. e1012874-e1012874
Open Access
New insights into transcription elongation control of HIV-1 latency and rebound
Uri Mbonye, Fredrick Kizito, Jonathan Karn
Trends in Immunology (2022) Vol. 44, Iss. 1, pp. 60-71
Open Access | Times Cited: 16
Synthesis and evaluation of DAG-lactone derivatives with HIV-1 latency reversing activity
Takahiro Ishii, Takuya Kobayakawa, Kouki Matsuda, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115449-115449
Open Access | Times Cited: 8
Interventions during Early Infection: Opening a Window for an HIV Cure?
Christopher R. Hiner, April L. Mueller, Hang Su, et al.
Viruses (2024) Vol. 16, Iss. 10, pp. 1588-1588
Open Access | Times Cited: 2
Discovering the Mechanisms of Wikstroelide E as a Potential HIV-Latency-Reversing Agent by Transcriptome Profiling
Shi-Fei Li, Liang Xue, Xingkang Wu, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 4, pp. 1022-1033
Closed Access | Times Cited: 15
Designed PKC-targeting bryostatin analogs modulate innate immunity and neuroinflammation
Efrat Abramson, Clayton Hardman, Akira Shimizu, et al.
Cell chemical biology (2021) Vol. 28, Iss. 4, pp. 537-545.e4
Open Access | Times Cited: 14
Total Synthesis and Biological Evaluation of the Potent HIV Latency-Reversing Agent Ansellone A and its Analogues
Mizushi Yanagihara, Kenichi Murai, Naoki Kishimoto, et al.
Organic Letters (2021) Vol. 23, Iss. 5, pp. 1720-1725
Closed Access | Times Cited: 14
Crotonylation sensitizes IAPi-induced disruption of latent HIV by enhancing p100 cleavage into p52
Dajiang Li, Morgan Dewey, Li Wang, et al.
iScience (2021) Vol. 25, Iss. 1, pp. 103649-103649
Open Access | Times Cited: 14
So Pathogenic or So What?—A Brief Overview of SIV Pathogenesis with an Emphasis on Cure Research
Adam J. Kleinman, Ivona Pandrea, Cristian Apetrei
Viruses (2022) Vol. 14, Iss. 1, pp. 135-135
Open Access | Times Cited: 8
Prodrug Therapies for Infectious and Neurodegenerative Diseases
Milica Marković, Suyash Deodhar, Jatin Machhi, et al.
Pharmaceutics (2022) Vol. 14, Iss. 3, pp. 518-518
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top